Novo Nordisk reported DKK37.36B in EBITDA for its fiscal quarter ending in June of 2026.





Ebitda Change Date
Bausch Health Companies USD 1.31B 230M Sep/2026
Bristol-Myers Squibb USD 3.48B 1.6B Sep/2026
Eli Lilly USD 9.46B 3.54B Sep/2026
GlaxoSmithKline GBP 3.51B 734M Jun/2026
Merck USD 1.42B 2.97B Jun/2026
Novartis USD 8.62B 2.14B Sep/2026
Novo Nordisk DKK 37.36B 2.64B Jun/2026
Novo Nordisk DKK 37.36B 31.84B Jun/2026
Pacira USD 50.45M 1.78M Sep/2026
Sanofi EUR 5.79B 2.1B Sep/2026
Supernus Pharmaceuticals USD 55.6M 24M Sep/2026